ClinicalTrials.gg

Brain Injuries, Traumatic clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 1,724 studies for Brain Injuries, Traumatic across more than 10 countries. 450 are recruiting or about to start. 1,184 of them are mainly about Brain Injuries, Traumatic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17. Counting its 3 narrower conditions too, such as Brain Concussion: 2,269 studies, 596 open.

ClinicalTrials.gov finds 2,683 studies for Brain Injuries, Traumatic. How that becomes 1,722 here

This page counts the studies the registry files under Brain Injuries, Traumatic, and those it files under no condition that list Brain Injuries, Traumaticthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 16, 2026. How condition pages count

  1. 2,683Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −509Filed under a narrower condition, counted on its own pageBrain Concussion 486 · Chronic Traumatic Encephalopathy 12 · Post-Concussion Syndrome 10
  3. −16List Brain Injuries, Traumatic as a condition, but the registry did not file them under itMost often written as “Brain Injury Traumatic Severe” (3), “Brain Injury Traumatic Severe (Diagnosis)” (2), and “Traumatic Brain Injury With Loss of Consciousness” (2). The registry filed them under other conditions only, most often Brain Injuries (6) and Consciousness Disorders (3).
  4. −437Match it another way128 name it in the title, 4 in a keyword, and 305 by a synonym or other text the search reads.
  5. 1,721Counted here and found by its search33 of them list Brain Injuries, Traumatic in their own words; the registry filed them under no condition.
  6. +1
    Counted here, but its search does not find them
  7. 1,722The count on this page

Status

Completed
803
Recruiting
284
Status unknown
214
Not yet recruiting
132
Terminated
119
Withdrawn
70

Phase

Phase 2
170
Phase 3
94
Phase 1
79
Phase 4
62
Early Phase 1
24

Where

United States
908
France
98
Canada
69
China
60
Italy
45
United Kingdom
45

Who develops what

Add Brain Injuries, Traumatic to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 2 programs from 2 companies, 1 with this as their studies’ main aim; 1 with a live phase 3 study; 0 primary completions in the next 12 months.

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

None given by two companies or more yet.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 2 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (0)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

None in the next 12 months.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Brain Injuries, Traumatic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Beta blockers 4 open · Local anesthetics 2 open · Stimulants 1 open · Statins 1 open · Serotonin receptor agonists 1 open

Coming up

152studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 284 Brain Injuries, Traumatic studies recruiting now, 123 (43%) set no upper age limit and 119 (42%) stop at 75 or younger. 40 (14%) take children under 18. 0 (0%) are for women only and 5 (2%) for men only; 53 (19%) take healthy volunteers.

Recruiting studies that take each age, of 284
AgeWomenMen
1023 (8%)23 (8%)
18253 (89%)256 (90%)
30255 (90%)259 (91%)
40254 (89%)258 (91%)
50256 (90%)261 (92%)
65231 (81%)234 (82%)
75180 (63%)183 (64%)
85140 (49%)142 (50%)

Across all 1,724 studies, recruiting or not: 46% stop at 75 or younger and 37% at 65; 20% take children; <1% are for women only and 2% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Brain Injuries, Traumatic studies take

Of 47 phase 2 interventional studies under Brain Injuries, Traumatic, half reached primary completion within 53 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 152 mo34–66 · 27 studies——
Phase 253 mo30–… · 47 studies——
Phase 348 mo19–69 · 30 studies——
Phase 443 mo8–148 · 25 studies——
Interventional, no phase41 mo22–64 · 466 studies—41 mo23–64 · 444 studies
Observational49 mo23–95 · 251 studies—50 mo23–95 · 229 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Newly registered14

Show 9 more

Studies

Recruiting first, then most recently updated. Showing 50 of 1,724. Browse all 1,724 → or search them.